Table 4.
Group | Before modeling | After modeling | After treatment |
---|---|---|---|
Control | 1.65 ± 0.35 | 1.75 ± 0.24 | 1.58 ± 0.44 |
Model | 1.58 ± 0.33 | 2.55 ± 0.21* | 2.67 ± 0.31* |
Baicalin | 1.35 ± 0.39 | 2.95 ± 0.42* | 2.09 ± 0.35# |
Berberine | 1.64 ± 0.41 | 2.63 ± 0.34* | 2.08 ± 0.36# |
Mixture | 1.55 ± 0.32 | 2.83 ± 0.25* | 2.16 ± 0.25# |
Nanoparticles | 1.72 ± 0.37 | 2.75 ± 0.52* | 1.92 ± 0.32# |
ANOVA with the post hoc test was used to calculate the significance of the differences, * and # represents P < 0.05 compared with the control and model group, respectively. The results are expressed as the mean ± S.D.